Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.42
-0.40 (-5.87%)
Mar 31, 2025, 1:30 PM EDT - Market open
Pulmonx Employees
Pulmonx had 291 employees as of December 31, 2024. The number of employees increased by 12 or 4.30% compared to the previous year.
Employees
291
Change (1Y)
12
Growth (1Y)
4.30%
Revenue / Employee
$287,935
Profits / Employee
-$193,794
Market Cap
255.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LUNG News
- 4 weeks ago - EDAP Appoints Glen French to Board of Directors - GlobeNewsWire
- 5 weeks ago - Top 3 Health Care Stocks You May Want To Dump In February - Benzinga
- 5 weeks ago - Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day - GlobeNewsWire
- 7 weeks ago - Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - GlobeNewsWire
- 4 months ago - Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers - Business Wire